Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP513778.RAEUZR624MaQ1e4hR15pLVmHg01_IwFx4K7fBlBHxvtCw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP513778.RAEUZR624MaQ1e4hR15pLVmHg01_IwFx4K7fBlBHxvtCw130_assertion type Assertion NP513778.RAEUZR624MaQ1e4hR15pLVmHg01_IwFx4K7fBlBHxvtCw130_head.
- NP513778.RAEUZR624MaQ1e4hR15pLVmHg01_IwFx4K7fBlBHxvtCw130_assertion description "[GISTs with low mRNA expression of the CDKN2A transcripts p16(INK4A) and p14(ARF) but high mRNA expression of CDK4, RB1, MDM2, TP53, and E2F1 were associated with aggressive clinical behavior and unfavorable prognosis, whereas GISTs with a low mRNA expression of CDK4, RB1, MDM2, TP53, and E2F1 were not.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513778.RAEUZR624MaQ1e4hR15pLVmHg01_IwFx4K7fBlBHxvtCw130_provenance.
- NP513778.RAEUZR624MaQ1e4hR15pLVmHg01_IwFx4K7fBlBHxvtCw130_assertion evidence source_evidence_literature NP513778.RAEUZR624MaQ1e4hR15pLVmHg01_IwFx4K7fBlBHxvtCw130_provenance.
- NP513778.RAEUZR624MaQ1e4hR15pLVmHg01_IwFx4K7fBlBHxvtCw130_assertion SIO_000772 16166437 NP513778.RAEUZR624MaQ1e4hR15pLVmHg01_IwFx4K7fBlBHxvtCw130_provenance.
- NP513778.RAEUZR624MaQ1e4hR15pLVmHg01_IwFx4K7fBlBHxvtCw130_assertion wasDerivedFrom befree-2016 NP513778.RAEUZR624MaQ1e4hR15pLVmHg01_IwFx4K7fBlBHxvtCw130_provenance.
- NP513778.RAEUZR624MaQ1e4hR15pLVmHg01_IwFx4K7fBlBHxvtCw130_assertion wasGeneratedBy ECO_0000203 NP513778.RAEUZR624MaQ1e4hR15pLVmHg01_IwFx4K7fBlBHxvtCw130_provenance.